FBR Capital

FBR Capital initiated coverage on Genocea Biosciences Inc (NASDAQ: GNCA) with a Outperform rating. The target price for Genocea Biosciences is set to $20. Genocea Biosciences shares have dropped 35.12 percent over the past 52 weeks, while the S&P 500 index has surged 11.75 percent in the same...

Analysts at FBR Capital initiated coverage on Regulus Therapeutics Inc (NASDAQ: RGLS) with a Outperform rating. The target price for Regulus Therapeutics is set to $30. Regulus Therapeutics shares have gained 133.42 percent over the past 52 weeks, while the S&P 500 index has surged 11.75...

FBR Capital upgraded Netflix, Inc. (NASDAQ: NFLX) from Market Perform to Outperform. The price target for Netflix has been raised from $400 to $900. Netflix shares have gained 37.52% over the past 52 weeks, while the S&P 500 index has surged 12.97% in the same period. Netflix shares climbed 12....

Analysts at FBR Capital downgraded Annaly Capital Management, Inc. (NYSE: NLY) from Market Perform to Underperform. The price target for Annaly Capital Management has been lowered from $12.00 to $10.00. Annaly Capital Management shares have dropped 8.44% over the past 52 weeks, while the S&P...

Analysts at FBR Capital initiated coverage on Demandware, Inc. (NYSE: DWRE) with a Outperform rating. The target price for Demandware is set to $70. Demandware shares have gained 8.52% over the past 52 weeks, while the S&P 500 index has surged 10.90% in the same period. Demandware's shares rose...

Analysts at FBR Capital initiated coverage on Pacific DataVision, Inc. (NASDAQ: PDVW) with a Outperform rating. The target price for Pacific DataVision is set to $77. Pacific DataVision's shares rose 0.99% to close at $49.99 yesterday.

Analysts at FBR Capital downgraded Gannett Co., Inc. (NYSE: GCI) from Outperform to Market Perform. The price target for Gannett is set to $38. Gannett shares have gained 35.82% over the past 52 weeks, while the S&P 500 index has surged 10.82% in the same period. Gannett's shares climbed 1.58%...

Analysts at FBR Capital downgraded FMC Technologies, Inc. (NYSE: FTI) from Market Perform to Underperform. The price target for FMC Technologies has been lowered from $50.00 to $31.00. FMC Technologies shares have dropped 25.89% over the past 52 weeks, while the S&P 500 index has surged 9.42%...

FBR Capital upgraded UTi Worldwide, Inc. (NASDAQ: UTIW) from Market Perform to Outperform. The price target for UTi Worldwide has been raised from $11.00 to $19.00. UTi Worldwide shares have gained 10.25% over the past 52 weeks, while the S&P 500 index has surged 10.34% in the same period. UTi...

Analysts at FBR Capital downgraded Crane Co. (NYSE: CR) from Outperform to Market Perform. The price target for Crane has been lowered from $77.00 to $67.00. Crane shares have dropped 4.31% over the past 52 weeks, while the S&P 500 index has surged 13.51% in the same period. Crane's shares fell...

FBR Capital upgraded Marvell Technology Group Ltd. (NASDAQ: MRVL) from Market Perform to Outperform. The price target for Marvell Technology Group has been raised from $19.00 to $21.00. Marvell Technology Group shares have gained 5.13% over the past 52 weeks, while the S&P 500 index has surged...

Analysts at FBR Capital upgraded Monster Worldwide, Inc. (NYSE: MWW) from Market Perform to Outperform. The price target for Monster Worldwide has been raised from $4.50 to $6.80. Monster Worldwide shares have dropped 30.77% over the past 52 weeks, while the S&P 500 index has surged 13.71% in...

Analysts at FBR Capital downgraded Visa Inc. (NYSE: V) from Outperform to Market Perform. The price target for Visa is set to $260. Visa shares have gained 15.12% over the past 52 weeks, while the S&P 500 index has surged 13.39% in the same period. Visa shares rose 3.91% to $257.70 in pre-...

Analysts at FBR Capital Markets issued the latest round of price target cuts for casino operators with heavy exposure to the Macau market. Analysts cited declining Macau gaming revenues in November and the first week of December as justification for the cuts. The Cuts FBR cut its price target...

On Tuesday, analysts at FBR Capital downgraded shares of Priceline Group Inc (NASDAQ: PCLN) from Outperform to Market Perform and maintained the $1,225 price target. FBR analyst Jake Fuller finds that Priceline’s growth is slowing and its margins are compressing. The analysts expects...